Chronos Archive seal
The Human Record

Josephine Baker

Case HR-ML049 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
June 3, 1906 – April 12, 1975
Synthetic DOB
1963-06-03
Index visit
2026-04-14 at age 62
Synthetic MRN
HR-ML049-SYN

Teaching objective: Secondary prevention in the first months after a non-ST-elevation myocardial infarction in a 62-year-old Black woman, an entertainer, veteran and civil rights activist under heavy financial strain, seen three weeks after a stent with breathlessness on exertion. The episode covers the care women, and Black women in particular, are less likely to receive after a heart attack, as AHA statements and registry data show: a full cardiology review, echocardiography, cardiac rehabilitation and every guideline-directed medicine. It teaches dual antiplatelet therapy for twelve months, recognizing ticagrelor-related breathlessness and switching to clopidogrel with a loading dose rather than stopping; high-intensity atorvastatin with an LDL goal below 70 mg/dL and a single lipoprotein(a) measurement; a beta-blocker for the first year and an ACE inhibitor for high blood pressure, with potassium and kidney checks (one missed check recorded honestly); depression screening after a heart attack with the PHQ-2 and PHQ-9, as the AHA advises; a nosebleed on dual antiplatelet therapy managed without stopping it; a graded return to the stage after an exercise test; the hysterectomy of her thirties as a possible early menopause and a risk-enhancing factor; and trauma-informed, respectful care that takes her account of her body seriously, under the 2023 AHA/ACC chronic coronary disease guideline, the 2025 ACC/AHA acute coronary syndromes guideline and the AHA statement on myocardial infarction in women.

Historical timeline

DateEventClaims
June 3, 1906Born Freda Josephine McDonald in St. Louis, Missouri.CLM-0001, CLM-0002
1925Comes to Paris with her troupe and performs at the Théâtre des Champs-Elysées.CLM-0003
1937Marries a Frenchman and becomes a French citizen.CLM-0004
June 1941Taken urgently to hospital in Casablanca after the loss of a pregnancy; in bed until December 1942, with five operations.CLM-0007, CLM-0008
1954 to 1965Adopts twelve children, raised at Les Milandes.CLM-0006
August 18, 1961Receives the Legion of Honor and the Croix de guerre with palm for her Resistance work.CLM-0005
August 28, 1963Speaks at the March on Washington for Jobs and Freedom.CLM-0009
June 2, 1964Televised appeal for donations to save Les Milandes from its debts.CLM-0010
March 1969Evicted from Les Milandes; has a heart attack the same day and is admitted to hospital in Périgueux.CLM-0011
1973Heart attack and stroke after a concert in Copenhagen.CLM-0012
April 12, 1975Dies in Paris of a cerebral hemorrhage, days after the opening of her fiftieth-anniversary revue at Bobino.CLM-0013
November 30, 2021Enters the Panthéon.CLM-0014

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D She was born Freda Josephine McDonald on June 3, 1906, in St. Louis, Missouri, to Carrie McDonald and Eddie Carson, into a family with little money.
Anchors the true birth date and the alias.
confirmed Josephine Baker supports
Joséphine Baker (Chemins de mémoire: personnalités) supports
Josephine Baker supports
HISTMED Master Roster v3 supports
D She grew up in poor neighborhoods of St. Louis and began working as a child; she married twice before the age of 16 and kept the surname of her second husband, William Howard Baker.
Social history only; the hardship of her childhood informs trauma-informed care.
confirmed Josephine Baker supports
Joséphine Baker (Chemins de mémoire: personnalités) supports
D She danced in New York in the musicals Shuffle Along and The Chocolate Dandies, came to Paris with her troupe in 1925 to perform at the Théâtre des Champs-Elysées, and became the most famous and highest-paid American performer in France.
Anchors her occupation as a performer in the modern social history.
confirmed Josephine Baker supports
Joséphine Baker (Chemins de mémoire: personnalités) supports
D She married a Frenchman in 1937 and became a French citizen; the National Park Service gives 1936.
The French Ministry of the Armed Forces and La Croix give 1937; the National Park Service page gives 1936. The record uses 1937.
probable Joséphine Baker (Chemins de mémoire: personnalités) supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Josephine Baker disputes
D During the Second World War she worked for the intelligence services of Free France with the rank of sub-lieutenant, gathering information and carrying messages written in invisible ink on her sheet music; on August 18, 1961, she received the Legion of Honor and the Croix de guerre with palm.
Anchors her strengths and her standing as a veteran in the modern social history.
confirmed Joséphine Baker (Chemins de mémoire: personnalités) supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Josephine Baker (Feminism and French Women in History: famous French women) supports
D She bought a château at Les Milandes in the Périgord, where she made a "village of the world" and raised twelve children of different nationalities and religions whom she had adopted during her tours with Jo Bouillon, her husband; the children were called the "Rainbow Tribe".
Documented history only; the children are not named in this record because some are living. Twelve is the number given by La Croix and by Women in World History (ten boys and two girls, adopted from 1954 to 1965); the National Women's History Museum gives 13.
probable Joséphine Baker (Chemins de mémoire: personnalités) supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports
Josephine Baker (biography) disputes
D In North Africa during the war she was taken urgently to hospital in Casablanca, where she stayed in bed from June 1941 to December 1942, had five operations and was several times reported to be dying; she continued her intelligence work from her room.
The documented anchor for her long, grave illness; the dates and the number of operations come from La Croix, and Women in World History agrees that she was critically ill and had several operations.
probable Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports
R The illness followed the loss of a pregnancy in 1941, given as a stillbirth in Casablanca by one source and as a miscarriage by another; the second account says a severe infection required a hysterectomy, after which she developed peritonitis and septicemia. La Croix says she was unable to have children.
Retrospective and partly conflicting account: stillbirth (Women in World History) or miscarriage (Women's History Network); the hysterectomy, peritonitis and septicemia rest on the Women's History Network alone. Whether her ovaries were removed is not recorded in any source read. Used, with this uncertainty, for the gynecologic history and the cardiovascular risk discussion.
possible Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports
Munro S. Josephine Baker (1906-1975). Women's History Network blog supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
D At the March on Washington for Jobs and Freedom on August 28, 1963, she was one of the few women to speak; she came in her military uniform with her decorations.
Anchors her civil rights work in the modern social history.
confirmed Josephine Baker supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Josephine Baker (biography) supports
D Les Milandes ran into heavy debt; she toured repeatedly to pay it, and on June 2, 1964, she made a televised appeal for donations, saying her work no longer covered debts of about 200 million old francs.
Anchors the financial strain in the modern social history.
confirmed Call for donations from Josephine Baker for the safeguarding of her castle in the Dordogne (television clip, June 2, 1964) supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
D In March 1969, after a court ordered her eviction, she was removed from the château and sat for seven hours in the rain on its steps; she had a new heart attack and ended the day in hospital in Périgueux. Les Milandes was sold at auction that year.
The documented anchor for the heart attack in the modern episode. The heart attack rests on La Croix alone and is called a new one, implying an earlier one that the sources read do not date. A heart attack in 1964, often repeated online, was not found in any reliable source and is not used.
probable Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports
D She was hospitalized several times for heart attacks and cerebral emboli in her last years; after a concert in Copenhagen in 1973 she had a heart attack and a stroke.
Later history, after the modern episode.
probable Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia supports
D On April 8, 1975, at Bobino in Paris, a revue celebrating her fifty years on the stage opened to a long ovation; a few days later she was found unconscious and she died in hospital in Paris of a cerebral hemorrhage on April 12, 1975, aged 68. Women in World History gives April 14.
The cause of death is a stroke from bleeding in the brain, not a heart attack. The date April 12 is given by the National Park Service, the Women's History Network and Biography.com; April 14 is recorded as a conflict.
probable Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports
Munro S. Josephine Baker (1906-1975). Women's History Network blog supports
Josephine Baker supports
Josephine Baker supports
Joséphine Baker (Chemins de mémoire: personnalités) supports
Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia disputes
HISTMED Master Roster v3 supports
D She is buried in Monaco; on November 30, 2021, she entered the Panthéon in Paris, the first Black woman to do so, with a cenotaph carried by air force personnel.
History after her death.
confirmed Joséphine Baker (Chemins de mémoire: personnalités) supports
Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 supports

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Breathlessness on exertion and tiredness since discharge three weeks after the heart attack, without chest pain at rest; cause to be determined (heart function, ischemia, anemia, medicine effect or deconditioning) resolved confirmed active
S Coronary artery disease after a non-ST-elevation myocardial infarction three weeks before intake, treated with one drug-eluting stent to the right coronary artery; synthetic modern episode linked to the documented heart attack of March 1969 active confirmed both_with_link CLM-0011
S High blood pressure, found during the hospital stay for the heart attack active confirmed active
S Absence of the uterus after an emergency hysterectomy at about 35, during a long, grave illness after the loss of a pregnancy; whether the ovaries were removed is not known; counted as a possible early menopause when weighing her cardiovascular risk active provisional both_with_link CLM-0007, CLM-0008
S Breathlessness from ticagrelor: a common, harmless side effect, resolved after the change to clopidogrel resolved confirmed active
S Raised lipoprotein(a), 172 nmol/L, an inherited risk-enhancing factor active confirmed active
S Financial strain: heavy debts after the loss of her home and estate, with income only from performing, which she has stopped while she recovers active confirmed active CLM-0010, CLM-0011
S Anterior nosebleed from the left side of the nose, lasting about 25 minutes, in dry weather on aspirin and clopidogrel; stopped with pressure; no further bleeding resolved confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-04-14 Hemoglobin [Mass/volume] in Blood 12.2 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-04-14 Platelets [#/volume] in Blood by Automated count 264 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-04-14 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-04-14 Potassium [Moles/volume] in Serum or Plasma 4.4 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-04-14 Creatinine [Mass/volume] in Serum or Plasma 0.82 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-04-14 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 81 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-04-14 Glucose [Mass/volume] in Serum or Plasma 94 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-04-14 Cholesterol [Mass/volume] in Serum or Plasma 152 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-04-14 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 84 mg/dL (high)
Reference Secondary-prevention goal below 70 mg/dL
http://loinc.org · 13457-7
S 2026-04-14 Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-04-14 Triglyceride [Mass/volume] in Serum or Plasma 80 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-04-14 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-04-14 Hemoglobin A1c/Hemoglobin.total in Blood 5.6%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-04-14 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 2 http://loinc.org · 55758-7
S 2026-04-14 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 7 http://loinc.org · 44261-6
S 2026-04-14 Overall summary score [SAQ] 70 http://loinc.org · 88474-2
S 2026-04-28 Lipoprotein a [Moles/volume] in Serum or Plasma 172 nmol/L (high)
Reference 125 nmol/L or higher is a risk-enhancing level
http://loinc.org · 43583-4
S 2026-04-28 Left ventricular Ejection fraction 52%
Reference 50-70%
http://loinc.org · 10230-1
S 2026-05-26 Sodium [Moles/volume] in Serum or Plasma 140 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-05-26 Potassium [Moles/volume] in Serum or Plasma 4.7 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-26 Creatinine [Mass/volume] in Serum or Plasma 0.88 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-05-26 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 74 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-26 Glucose [Mass/volume] in Serum or Plasma 92 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-05-26 Overall summary score [SAQ] 84 http://loinc.org · 88474-2
S 2026-06-16 Hemoglobin [Mass/volume] in Blood 11.9 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-06-16 Platelets [#/volume] in Blood by Automated count 258 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-07-21 Cholesterol [Mass/volume] in Serum or Plasma 128 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-07-21 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 62 mg/dL
Reference Secondary-prevention goal below 70 mg/dL
http://loinc.org · 13457-7
S 2026-07-21 Cholesterol in HDL [Mass/volume] in Serum or Plasma 54 mg/dL
Reference >=50 mg/dL
http://loinc.org · 2085-9
S 2026-07-21 Triglyceride [Mass/volume] in Serum or Plasma 72 mg/dL
Reference <=149 mg/dL
http://loinc.org · 2571-8
S 2026-07-21 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-35 U/L
http://loinc.org · 1742-6
S 2026-07-21 Patient Health Questionnaire 9 item (PHQ-9) total score [Reported] 3 http://loinc.org · 44261-6
S 2026-07-21 Overall summary score [SAQ] 94 http://loinc.org · 88474-2
S 2026-09-15 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-20 Hemoglobin [Mass/volume] in Blood 12.4 g/dL
Reference 11.6-15 g/dL
http://loinc.org · 718-7
S 2026-10-20 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-10-20 Potassium [Moles/volume] in Serum or Plasma 4.5 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-10-20 Creatinine [Mass/volume] in Serum or Plasma 0.84 mg/dL
Reference 0.59-1.04 mg/dL
http://loinc.org · 2160-0
S 2026-10-20 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 78 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-10-20 Glucose [Mass/volume] in Serum or Plasma 93 mg/dL
Reference 70-99 mg/dL
http://loinc.org · 2345-7
S 2026-10-20 Overall summary score [SAQ] 96 http://loinc.org · 88474-2
S 2026-09-15 Total score [AUDIT-C] 1 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-04-14Body height168 cm8302-2S
2026-04-14Body weight59.8 kg29463-7S
2026-04-14Body mass index (BMI) [Ratio]21.2 kg/m239156-5S
2026-04-14Systolic blood pressure138 mm[Hg]8480-6S
2026-04-14Diastolic blood pressure84 mm[Hg]8462-4S
2026-04-14Heart rate64 /min8867-4S
2026-04-14Respiratory rate16 /min9279-1S
2026-04-14Body temperature36.6 Cel8310-5S
2026-04-14Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-04-28Body height168 cm8302-2S
2026-04-28Body weight59.6 kg29463-7S
2026-04-28Body mass index (BMI) [Ratio]21.1 kg/m239156-5S
2026-04-28Systolic blood pressure136 mm[Hg]8480-6S
2026-04-28Diastolic blood pressure82 mm[Hg]8462-4S
2026-04-28Heart rate62 /min8867-4S
2026-04-28Respiratory rate16 /min9279-1S
2026-04-28Body temperature36.7 Cel8310-5S
2026-04-28Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-05-26Body height168 cm8302-2S
2026-05-26Body weight59.9 kg29463-7S
2026-05-26Body mass index (BMI) [Ratio]21.2 kg/m239156-5S
2026-05-26Systolic blood pressure126 mm[Hg]8480-6S
2026-05-26Diastolic blood pressure78 mm[Hg]8462-4S
2026-05-26Heart rate60 /min8867-4S
2026-05-26Respiratory rate14 /min9279-1S
2026-05-26Body temperature36.6 Cel8310-5S
2026-05-26Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-07-21Body height168 cm8302-2S
2026-07-21Body weight60.4 kg29463-7S
2026-07-21Body mass index (BMI) [Ratio]21.4 kg/m239156-5S
2026-07-21Systolic blood pressure122 mm[Hg]8480-6S
2026-07-21Diastolic blood pressure76 mm[Hg]8462-4S
2026-07-21Heart rate58 /min8867-4S
2026-07-21Respiratory rate14 /min9279-1S
2026-07-21Body temperature36.5 Cel8310-5S
2026-07-21Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-10-20Body height168 cm8302-2S
2026-10-20Body weight60.6 kg29463-7S
2026-10-20Body mass index (BMI) [Ratio]21.5 kg/m239156-5S
2026-10-20Systolic blood pressure122 mm[Hg]8480-6S
2026-10-20Diastolic blood pressure74 mm[Hg]8462-4S
2026-10-20Heart rate58 /min8867-4S
2026-10-20Respiratory rate14 /min9279-1S
2026-10-20Body temperature36.6 Cel8310-5S
2026-10-20Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-06-16Body height168 cm8302-2S
2026-06-16Body weight60.2 kg29463-7S
2026-06-16Body mass index (BMI) [Ratio]21.3 kg/m239156-5S
2026-06-16Systolic blood pressure132 mm[Hg]8480-6S
2026-06-16Diastolic blood pressure80 mm[Hg]8462-4S
2026-06-16Heart rate70 /min8867-4S
2026-06-16Respiratory rate16 /min9279-1S
2026-06-16Body temperature36.6 Cel8310-5S
2026-06-16Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-15Body height168 cm8302-2S
2026-09-15Body weight60.6 kg29463-7S
2026-09-15Body mass index (BMI) [Ratio]21.5 kg/m239156-5S
2026-09-15Systolic blood pressure124 mm[Hg]8480-6S
2026-09-15Diastolic blood pressure76 mm[Hg]8462-4S
2026-09-15Heart rate58 /min8867-4S
2026-09-15Respiratory rate14 /min9279-1S
2026-09-15Body temperature36.6 Cel8310-5S
2026-09-15Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

No family medical history is documented in the logged sources. Family history of real relatives is never synthesized.

Care-plan goals

GoalTarget dateStatusOutcome
Twelve months of dual antiplatelet therapy from the heart attack without interruption2027-03-24activeSeven months completed without a missed dose; changed from ticagrelor to clopidogrel without a gap
LDL cholesterol below 70 mg/dL with at least a 50% fall2026-07-21completedLDL 62 mg/dL, a 58% fall from 146
Blood pressure below 130/80 mmHg2026-05-26completed126/78 in the clinic; home average 124/76
Complete cardiac rehabilitation and return to performing2026-07-21completedExercise test to about 10 METs without ischemia; graded return to rehearsals agreed
Mood: PHQ-9 below 5 by twelve weeks2026-07-21completedPHQ-9 7 to 3

Interventions

InterventionStatusGuideline
Respectful, trauma-informed shared decisions: take her account of her symptoms seriously, explain each medicine and its reason plainly, write the plan down, and check costs with her before prescribingcompletedGL-AHA-WOMEN-MI-2016, GL-GWTG-DISPARITY-2016, GL-CCD-2023
Cardiology consultation on the day of the two-week visit, with an echocardiogram, to find the cause of the breathlessness, review the antiplatelet choice and the other medicines, and advise on rehabilitation and a return to the stagecompletedGL-CCD-2023, GL-ACS-2025, GL-CMID-2026
Dual antiplatelet therapy, aspirin 81 mg with a P2Y12 inhibitor, for twelve months from the heart attack, never stopped without speaking to cardiology; then aspirin alonecompletedGL-ACS-2025, GL-CCD-2023, GL-CMID-2026
Atorvastatin 80 mg daily; lipid panel four to eight weeks after the start; goal LDL below 70 mg/dL with at least a 50% fall; lipoprotein(a) measured oncecompletedGL-CCD-2023, GL-CMID-2026
Metoprolol succinate for at least the first year after the heart attack; lisinopril for high blood pressure, with home readings and a target below 130/80 mmHg; potassium and creatinine one to two weeks after any dose changecompletedGL-CCD-2023, GL-CMID-2026
Enroll in a 36-session outpatient cardiac rehabilitation program, starting within two weeks, with exercise training, nutrition, stress management and psychological support; the clinic will call her if she misses sessionscompletedGL-CCD-2023, GL-AHA-WOMEN-MI-2016, GL-CMID-2026
Depression after a heart attack: PHQ-2 and PHQ-9 today, repeat PHQ-9 at about twelve weeks, the rehabilitation program's psychologist, and a lower threshold for treatment if symptoms risecompletedGL-AHA-DEP-2008, GL-AHA-DEP-ACS-2014, GL-CCD-2023
Chest-pain action plan: nitroglycerin under the tongue, and 911 if pain is not better five minutes after the first tablet; warning symptoms in women, such as breathlessness, unusual tiredness, nausea or jaw, back or arm discomfort, explainedcompletedGL-AHA-WOMEN-MI-2016, GL-CCD-2023
Costs: generic medicines in 90-day fills, the clinic social worker for debt advice and help with medicine costs, and rehabilitation sessions at times that fit her familycompletedGL-CCD-2023
Women's cardiovascular risk: record the hysterectomy of her thirties and a possible early menopause as a risk-enhancing factor; hormone therapy is not used to prevent heart diseasecompletedGL-AHA-MENO-2020, GL-AHA-WOMEN-MI-2016
Change ticagrelor to clopidogrel for ticagrelor-related breathlessness: 600 mg loading dose 24 hours after the last ticagrelor, then 75 mg daily, without a gap in antiplatelet covercompletedGL-ACS-2025, GL-CCD-2023
Raise lisinopril to 10 mg daily for blood pressure above target, with potassium and creatinine one to two weeks latercompletedGL-CCD-2023, GL-CMID-2026
Laboratory tests drawn at the rehabilitation center on session days, so that no check needs a separate tripcompletedGL-CMID-2026
Nosebleed plan on dual antiplatelet therapy: firm pressure on the soft part of the nose for 15 minutes, saline spray and a humidifier; do not stop aspirin or clopidogrel; come in if bleeding lasts more than 30 minutescompletedGL-AAO-EPISTAXIS-2020, GL-ACS-2025
Graded return to the stage: rehearsals at the effort reached in rehabilitation, then full performances, with rest between shows, water, and nitroglycerin in the dressing roomcompletedGL-CCD-2023

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Joséphine Baker (Chemins de mémoire: personnalités) Ministère des Armées, France (Direction de la mémoire, de la culture et des archives) government
SRC-0002 Josephine Baker National Park Service (a National Historic Site in Washington, D.C.) government
SRC-0003 Raspiengeas JC. Joséphine Baker: les mille vies du Phénix (dossier). La Croix L'Hebdo, November 2021 Bayard Presse (La Croix), reproduced by the Château des Milandes other
SRC-0004 Ojala JA. Baker, Josephine (1906-1975). Women in World History: A Biographical Encyclopedia Gale, via Encyclopedia.com biography
SRC-0005 Munro S. Josephine Baker (1906-1975). Women's History Network blog Women's History Network biography
SRC-0006 Call for donations from Josephine Baker for the safeguarding of her castle in the Dordogne (television clip, June 2, 1964) Institut national de l'audiovisuel (INA) other
SRC-0007 Josephine Baker Biography.com (A&E Television Networks) biography
SRC-0008 Josephine Baker (Feminism and French Women in History: famous French women) Library of Congress research guide government
SRC-0009 HISTMED Master Roster v3 The Human Record project other
SRC-0010 Josephine Baker (biography) National Women's History Museum biography

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the attribution of breathlessness to ticagrelor and the switch to clopidogrel with a 600 mg load, twelve months of dual antiplatelet therapy, metoprolol with an ejection fraction of 52%, lisinopril for blood pressure, the missed potassium check, the nosebleed managed without stopping antiplatelets, the exercise test before a return to the stage, the hysterectomy counted as a possible early menopause, and PHQ-9 scores below 10 without a safety assessment.
provenance reviewnot_startedSources: the French Ministry of the Armed Forces, the National Park Service, a La Croix dossier hosted by the Château des Milandes, Women in World History, the Women's History Network, the INA archive, Biography.com, a Library of Congress guide and the National Women's History Museum. The Panthéon (Centre des monuments nationaux) site, the Smithsonian NMAAHC page and the New York Times obituary could not be fetched; Jean-Claude Baker's and Bennetta Jules-Rosette's books were not read. A heart attack in 1964 could not be verified and is not used.
safe messaging reviewnot_startedPoverty, racism, the pregnancy loss and the eviction are recorded plainly as history, without graphic detail. The claim about the pregnancy loss and hysterectomy is marked sensitive. Mood screening is synthetic and below the threshold for a safety assessment. Her adopted children are not named, and no relative or other real person is given a modern statement, decision or health fact.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.